Home
Live Updates
FDA Grants ODD to Utidelone Capsules For Treatment of Gastric Cancer : comparemela.com
FDA Grants ODD to Utidelone Capsules For Treatment of Gastric Cancer
The orphan drug designation is a result of positive findings from a phase 2 clinical trial which demonstrated a 100% clinical benefit rate in patients.
Related Keywords
,
Biostar Pharma Utidelone ,
Biostar Pharma ,
Li Tang ,
Sebastian Kaulitzki ,
Biostar Pharma Inc ,
Hanmi Pharmaceuticals ,
Kinex Pharmaceuticals ,
Biostar Pharmaceuticals ,
Utidelone Capsule ,
Patients With Advanced Solid ,
Odonate Therapeutics ,
Biostar Pharma Announces First Patient Enrolled ,
First Oral Epothilone Anti Cancer ,
comparemela.com © 2020. All Rights Reserved.